Jazz Pharmaceuticals (JAZZ) Accounts Payables (2010 - 2026)
Jazz Pharmaceuticals (JAZZ) posted quarterly Accounts Payables of $100.0 million for Q1 2026, up 4.24% year-over-year from $95.9 million in Q1 2025, and down 18.1% quarter-over-quarter from $122.1 million in Q4 2025.
Jazz Pharmaceuticals (JAZZ) Accounts Payables (2010 - 2026) Analysis & Trends
Jazz Pharmaceuticals' Accounts Payables history runs 17 years deep, the most recent figure standing at $100.0 million for Q1 2026.
- In Q1 2026, Accounts Payables rose 4.24% year-over-year to $100.0 million; the TTM figure through Mar 2026 stood at $100.0 million (up 4.24% YoY), while the FY2025 annual figure was $122.1 million, up 56.8% from the prior year.
- Accounts Payables for Q1 2026 stood at $100.0 million, down from $122.1 million in the prior quarter.
- The five-year high for Accounts Payables was $152.2 million in Q3 2025, with the low at $73.3 million in Q1 2022.
- The 5-year median for Accounts Payables is $97.1 million (2024), against an average of $98.7 million.
- The sharpest annual moves came in 2024 and 2025: Accounts Payables tumbled 35.45% in 2024, then jumped 78.2% in 2025.
- Jazz Pharmaceuticals' Accounts Payables stood at $90.8 million in 2022, then increased by 13.21% to $102.8 million in 2023, then fell by 24.22% to $77.9 million in 2024, then surged by 56.8% to $122.1 million in 2025, then dropped by 18.1% to $100.0 million in 2026.
- Business Quant data shows JAZZ's Accounts Payables at $100.0 million in Q1 2026, $122.1 million in Q4 2025, and $152.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Jazz Pharmaceuticals | 15.90 Bn | 14.28 Bn | 1.09 Bn | 128.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 128.50 Mn |
| Mar 31, 2026 | 100.00 Mn |
| Dec 31, 2025 | 122.10 Mn |
| Sep 30, 2025 | 152.23 Mn |
| Jun 30, 2025 | 89.37 Mn |
| Mar 31, 2025 | 95.93 Mn |
| Dec 31, 2024 | 77.87 Mn |
| Sep 30, 2024 | 85.43 Mn |
| Jun 30, 2024 | 97.10 Mn |
| Mar 31, 2024 | 80.98 Mn |
| Dec 31, 2023 | 102.75 Mn |
| Sep 30, 2023 | 109.85 Mn |
| Jun 30, 2023 | 98.43 Mn |
| Mar 31, 2023 | 125.45 Mn |
| Dec 31, 2022 | 90.76 Mn |
| Sep 30, 2022 | 102.25 Mn |
| Jun 30, 2022 | 74.16 Mn |
| Mar 31, 2022 | 73.34 Mn |
| Dec 31, 2021 | 100.30 Mn |
| Sep 30, 2021 | 63.82 Mn |